BAK1 antibody (N-Term)
Quick Overview for BAK1 antibody (N-Term) (ABIN184699)
Target
See all BAK1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- N-Term
-
Purpose
- BAK1
-
Sequence
- ASGQGPGPPR QE
-
Cross-Reactivity
- Human, Mouse, Pig, Rat
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence ASGQGPGPPRQE-C, from the N Terminus of the protein sequence according to NP_001179.1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: Approx 25 kDa band observed in Human Adrenal Gland lysates and in preliminary testing of HeLa and Jurkat cell lyate (calculated MW of 23.4 kDa according to NP_001179.1. Recommended concentration: 0.5-1 μg/mL. Primary incubation 1 hour at room
Peptide ELISA: antibody detection limit dilution 1:32000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- BAK1 (BCL2-Antagonist/killer 1 (BAK1))
-
Alternative Name
- BAK1
-
Background
- BAK1, BCL2-antagonist/killer 1, BAK, CDN1, BCL2L7, cell death inhibitor 1, apoptosis regulator BAK, Bcl-2 homologous antagonist/killer, BAK-LIKE, MGC117255, MGC3887, BCL2-like 7 protein, pro-apoptotic protein BAK
-
Gene ID
- 578, 12018, 116502
-
NCBI Accession
- NP_001179
-
Pathways
- Apoptosis, Steroid Hormone Mediated Signaling Pathway, ER-Nucleus Signaling, Positive Regulation of Endopeptidase Activity, Unfolded Protein Response
Target
-